Genetic variations in Vitamin D-related pathways and breast cancer risk in African American women in the AMBER consortium

International Journal of Cancer

Volumn 138, Issue 9, 2016, Pages 2118-2126

  Yao, Song ^a   Haddad, Stephen A ^b   Hu, Qiang ^a   Liu, Song ^a   Lunetta, Kathryn L ^c   Ruiz Narvaez, Edward A ^b   Hong, Chi Chen ^a   Zhu, Qianqian ^a   Sucheston Campbell, Lara ^a   Cheng, Ting Yuan David ^a   Bensen, Jeannette T ^d   Johnson, Candace S ^a   Trump, Donald L ^e   Haiman, Christopher A ^f   Olshan, Andrew F ^d   Palmer, Julie R ^b   Ambrosone, Christine B ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b BOSTON UNIVERSITY   (United States)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^d University of North Carolina at Chapel Hill   (United States)

^e Inova Dwight and Martha Schar Cancer Institute   (United States)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

African American; breast cancer; estrogen receptor; genetic variation; Vitamin D

Indexed keywords

CALCIUM SENSING RECEPTOR; ESTROGEN RECEPTOR; VITAMIN D; CASR PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BREAST CANCER; CANCER RISK; CASR GENE; CONTROLLED STUDY; DDB2 GENE; FEMALE; GENE; GENETIC RISK; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; ODDS RATIO; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; VITAMIN D METABOLISM; ADOLESCENT; BIOSYNTHESIS; BREAST TUMOR; GENETIC PREDISPOSITION; GENETIC VARIATION; GENETICS; GENOTYPE; METABOLISM; MIDDLE AGED; RISK FACTOR; YOUNG ADULT;

ADOLESCENT; ADULT; AFRICAN AMERICANS; AGED; BIOMARKERS, TUMOR; BREAST NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HUMANS; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CALCIUM-SENSING; RECEPTORS, ESTROGEN; RISK FACTORS; VITAMIN D; YOUNG ADULT;

EID: 84958943528     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29954     Document Type: Article

References (50)

1. Deeb KK, Trump DL, Johnson CS., Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer 2007; 7: 684-700.
2. Feldman D, Krishnan AV, Swami S, et al., The role of vitamin D in reducing cancer risk and progression. Nat Rev Cancer 2014; 14: 342-57.
3. Grant WB., A multicountry ecological study of cancer incidence rates in 2008 with respect to various risk-modifying factors. Nutrients 2014; 6: 163-89.
4. Kim Y, Je Y., Vitamin D intake, blood 25(OH)D levels, and breast cancer risk or mortality: a meta-analysis. Br J Cancer 2014; 110: 2772-84.
5. Chung M, Lee J, Terasawa T, et al., Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the U.S. Preventive Services Task Force. Ann Intern Med 2011; 155: 827-38.
6. Chlebowski RT., Vitamin D and breast cancer: interpreting current evidence. Breast Cancer Res 2011; 13: 217.
7. Mun MJ, Kim TH, Hwang JY, et al., Vitamin D receptor gene polymorphisms and the risk for female reproductive cancers: a meta-analysis. Maturitas 2015; 81: 256-65.
8. Raimondi S, Johansson H, Maisonneuve P, et al., Review and meta-analysis on vitamin D receptor polymorphisms and cancer risk. Carcinogenesis 2009; 30: 1170-80.
9. Zhang K, Song L., Association between vitamin D receptor gene polymorphisms and breast cancer risk: a meta-analysis of 39 studies. PLoS One 2014; 9: e96125.
10. Yao S, Ambrosone CB., Associations between vitamin D deficiency and risk of aggressive breast cancer in African-American women. J Steroid Biochem Mol Biol 2013; 136: 337-41.
11. Yao S, Zirpoli G, Bovbjerg DH, et al,. Variants in the vitamin D pathway, serum levels of vitamin D, and estrogen receptor negative breast cancer among African-American women: a case-control study. Breast Cancer Res 2012; 14: R58.
12. Anderson WF, Rosenberg PS, Prat A, Perou CM, Sherman ME., How many etiological subtypes of breast cancer: two, three, four, or more? J Natl Cancer Inst 2014; 106. pii: dju165.
13. Yao S, Sucheston LE, Millen AE, et al,. Pretreatment serum concentrations of 25-hydroxyvitamin D and breast cancer prognostic characteristics: a case-control and a case-series study. PLoS One 2011; 6: e17251.
14. Palmer JR, Ambrosone CB, Olshan AF., A collaborative study of the etiology of breast cancer subtypes in African American women: the AMBER consortium. Cancer Causes Control 2014; 25: 309-19.
15. Newman B, Moorman PG, Millikan R, et al., The Carolina Breast Cancer Study: integrating population-based epidemiology and molecular biology. Breast Cancer Res Treat 1995; 35: 51-60.
16. Ambrosone CB, Ciupak GL, Bandera EV, et al,. Conducting molecular epidemiological research in the age of HIPAA: a multi-institutional case-control study of breast cancer in African-American and European-American Women. J Oncol 2009; 2009: 871250.
17. Bandera EV, Chandran U, Zirpoli G, et al,. Rethinking sources of representative controls for the conduct of case-control studies in minority populations. BMC Med Res Methodol 2013; 13: 71.
18. Rosenberg L, Adams-Campbell L, Palmer JR., The Black Women's Health Study: a follow-up study for causes and preventions of illness. J Am Med Womens Assoc 1995; 50: 56-8.
19. Kolonel LN, Henderson BE, Hankin JH, et al,. A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. Am J Epidemiol 2000; 151: 346-57.
20. Subramanian A, Tamayo P, Mootha VK, et al,. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005; 102: 15545-50.
21. Abecasis GR, Auton A, Brooks LD, et al,. An integrated map of genetic variation from 1,092 human genomes. Nature 2012; 491: 56-65.
22. Laurie CC, Doheny KF, Mirel DB, et al,. Quality control and quality assurance in genotypic data for genome-wide association studies. Genet Epidemiol 2010; 34: 591-602.
23. Howie BN, Donnelly P, Marchini J., A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet 2009; 5: e1000529.
24. Price AL, Patterson NJ, Plenge RM, et al,. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006; 38: 904-9.
25. Purcell S, Neale B, Todd-Brown K, et al,. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559-75.
26. Yu K, Li Q, Bergen AW, et al,. Pathway analysis by adaptive combination of P-values. Genet Epidemiol 2009; 33: 700-9.
27. Gao X., Multiple testing corrections for imputed SNPs. Genet Epidemiol 2011; 35: 154-8.
28. Pruim RJ, Welch RP, Sanna S, et al,. LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics 2010; 26: 2336-7.
29. Ahn J, Yu K, Stolzenberg-Solomon R, et al,. Genome-wide association study of circulating vitamin D levels. Hum Mol Genet 2010; 19: 2739-45.
30. Wang TJ, Zhang F, Richards JB, et al,. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 2010; 376: 180-8.
31. Mondul AM, Shui IM, Yu K, et al,. Vitamin D-associated genetic variation and risk of breast cancer in the breast and prostate cancer cohort consortium (BPC3). Cancer Epidemiol Biomarkers Prev 2015; 24: 627-30.
32. Ambrosone CB, Zirpoli G, Hong CC, et al,. Important role of menarche in development of estrogen receptor-negative breast cancer in African American Women. J Natl Cancer Inst 2015; 107. pii: djv172.
33. Palmer JR, Viscidi E, Troester MA, et al,. Parity, lactation, and breast cancer subtypes in African American women: results from the AMBER Consortium. J Natl Cancer Inst 2014; 106. pii: dju237.
34. Rosenberg L, Bethea TN, Viscidi E, et al,. Postmenopausal female hormone use and risk of estrogen receptor positive and negative breast cancer in African American women. J Natl Cancer Inst 2015;108:pii: djv361.
35. Hatse S, Lambrechts D, Verstuyf A, et al,. Vitamin D status at breast cancer diagnosis: correlation with tumor characteristics, disease outcome, and genetic determinants of vitamin D insufficiency. Carcinogenesis 2012; 33: 1319-26.
36. Tretli S, Schwartz GG, Torjesen PA, et al,. Serum levels of 25-hydroxyvitamin D and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: a population-based study. Cancer Causes Control 2012; 23: 363-70.
37. Villasenor A, Ballard-Barbash R, Ambs A, et al,. Associations of serum 25-hydroxyvitamin D with overall and breast cancer-specific mortality in a multiethnic cohort of breast cancer survivors. Cancer Causes Control 2013; 24: 759-67.
38. Vrieling A, Hein R, Abbas S, et al,. Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study. Breast Cancer Res 2011; 13: R74.
39. Shui IM, Mucci LA, Kraft P, et al,. Vitamin D-related genetic variation, plasma vitamin D, and risk of lethal prostate cancer: a prospective nested case-control study. J Natl Cancer Inst 2012; 104: 690.
40. Pendas-Franco N, Gonzalez-Sancho JM, Suarez Y, et al,. Vitamin D regulates the phenotype of human breast cancer cells. Differentiation 2007; 75: 193-207.
41. Zhang Y, Leung DY, Richers BN, et al,. Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1. J Immunol 2012; 188: 2127-35.
42. Pervin S, Hewison M, Braga M, et al,. Down-regulation of vitamin D receptor in mammospheres: implications for vitamin D resistance in breast cancer and potential for combination therapy. PLoS One 2013; 8: e53287.
43. Eliassen AH, Spiegelman D, Hollis BW, et al,. Plasma 25-hydroxyvitamin D and risk of breast cancer in the Nurses' Health Study II. Breast Cancer Res 2011; 13: R50.
44. Brennan SC, Thiem U, Roth S, et al,. Calcium sensing receptor signalling in physiology and cancer. Biochim Biophys Acta 2013; 1833: 1732-44.
45. Shui IM, Mucci LA, Wilson KM, et al,. Common genetic variation of the calcium-sensing receptor and lethal prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2013; 22: 118-26.
46. Li X, Kong X, Jiang L, et al,. A genetic polymorphism (rs17251221) in the calcium-sensing receptor is associated with breast cancer susceptibility and prognosis. Cell Physiol Biochem 2014; 33: 165-72.
47. Gong Z, Quan L, Yao S, et al,. Innate immunity pathways and breast cancer Risk in African American and European-American women in the Women's Circle of Health Study (WCHS). PLoS One 2013; 8: e72619.
48. Quan L, Gong Z, Yao S, et al,. Cytokine and cytokine receptor genes of the adaptive immune response are differentially associated with breast cancer risk in American women of African and European ancestry. Int J Cancer 2014; 134: 1408-21.
49. Quan L, Hong CC, Zirpoli G, et al,. Variants of estrogen-related genes and breast cancer risk in European and African American women. Endocr Relat Cancer 2014; 21: 853-64.
50. Yao S, Graham K, Shen J, et al,. Genetic variants in microRNAs and breast cancer risk in African American and European American women. Breast Cancer Res Treat 2013; 141: 447-59.